A Medical Device Daily

Banyan Biomarkers (Alachua, Florida) reported that the U.S. Patent and Trademark Office has granted U.S. Patent No. 7,396,654 B2 "Neural Proteins as Biomarkers for Traumatic Brain Injury," licensed exclusively by Banyan from the University of Florida (Gainesville).

Specifically, the patent covers the detection of certain neuronal protein markers found in the blood of patients suffering from neural injury and/or neuronal damage. The patent also covers certain sensitive and rapid methods and test kits that can be used as tools for the diagnosis of neural injuries and/or neuronal disorders such as brain injury, neural damage due to drug or alcohol addiction and diseases associated with the brain and central nervous system.

Banyan also holds the exclusive license from the University of Florida for U.S. Patent No. 7,291,710 "Detection of spectrin and spectrin proteolytic cleavage products in assessing nerve cell damage."

Banyan develops in vitro diagnostic products to address unmet clinical needs for the detection of traumatic brain injury.